Metastasis of Prostate Cancer
Without metastasis, prostate cancer would be both tolerable and treatable. The high incidence of indolent and organ confined disease is testament to this sweeping generalisation. Equally, if molecular markers of metastatic spread can be identified, then the choice of treatment for many patients would be easier and more radical, even curative. However, should prevention and treatment of the primary tumors prove difficult or impossible, then a knowledge of the phenotype of advanced metastatic tumors should allow us to target these lesions for destruction by conventional (drug based) or more innovative means such as gene and/or immunotherapy (1). The process of metastasis has been reviewed many times (e. g. , 2) and has been subdivided for ease of analysis into a number of discrete stages (see Figure 1). It has been suggested that at least 10 separate genetic 2. ECM degradation: migration MMP ; Integrin ; TIMP 3. Intravasation MMP TIMP 1. Cellular independence 4. Transport Adhesion loss and evasion (E Cadherin ) of host immune system MHCClass1 ICAM-1 to block T cell receptor 5. Arrest of movement: endothelial adhesion CD44 or switch 6. Extravasation to colonise new site 7. Proliferation at Laminin R distant site to form Integrin switch METASTASIS Figure 1. Stages in prostate cancer metastasis. Basic processes in tumor metastases are indicated in the boxes with some key changes in gene expression indicated at each stage by the solid arrows.
1120494996
Metastasis of Prostate Cancer
Without metastasis, prostate cancer would be both tolerable and treatable. The high incidence of indolent and organ confined disease is testament to this sweeping generalisation. Equally, if molecular markers of metastatic spread can be identified, then the choice of treatment for many patients would be easier and more radical, even curative. However, should prevention and treatment of the primary tumors prove difficult or impossible, then a knowledge of the phenotype of advanced metastatic tumors should allow us to target these lesions for destruction by conventional (drug based) or more innovative means such as gene and/or immunotherapy (1). The process of metastasis has been reviewed many times (e. g. , 2) and has been subdivided for ease of analysis into a number of discrete stages (see Figure 1). It has been suggested that at least 10 separate genetic 2. ECM degradation: migration MMP ; Integrin ; TIMP 3. Intravasation MMP TIMP 1. Cellular independence 4. Transport Adhesion loss and evasion (E Cadherin ) of host immune system MHCClass1 ICAM-1 to block T cell receptor 5. Arrest of movement: endothelial adhesion CD44 or switch 6. Extravasation to colonise new site 7. Proliferation at Laminin R distant site to form Integrin switch METASTASIS Figure 1. Stages in prostate cancer metastasis. Basic processes in tumor metastases are indicated in the boxes with some key changes in gene expression indicated at each stage by the solid arrows.
229.99 In Stock
Metastasis of Prostate Cancer

Metastasis of Prostate Cancer

Metastasis of Prostate Cancer

Metastasis of Prostate Cancer

Paperback(2007)

$229.99 
  • SHIP THIS ITEM
    In stock. Ships in 6-10 days.
  • PICK UP IN STORE

    Your local store may have stock of this item.

Related collections and offers


Overview

Without metastasis, prostate cancer would be both tolerable and treatable. The high incidence of indolent and organ confined disease is testament to this sweeping generalisation. Equally, if molecular markers of metastatic spread can be identified, then the choice of treatment for many patients would be easier and more radical, even curative. However, should prevention and treatment of the primary tumors prove difficult or impossible, then a knowledge of the phenotype of advanced metastatic tumors should allow us to target these lesions for destruction by conventional (drug based) or more innovative means such as gene and/or immunotherapy (1). The process of metastasis has been reviewed many times (e. g. , 2) and has been subdivided for ease of analysis into a number of discrete stages (see Figure 1). It has been suggested that at least 10 separate genetic 2. ECM degradation: migration MMP ; Integrin ; TIMP 3. Intravasation MMP TIMP 1. Cellular independence 4. Transport Adhesion loss and evasion (E Cadherin ) of host immune system MHCClass1 ICAM-1 to block T cell receptor 5. Arrest of movement: endothelial adhesion CD44 or switch 6. Extravasation to colonise new site 7. Proliferation at Laminin R distant site to form Integrin switch METASTASIS Figure 1. Stages in prostate cancer metastasis. Basic processes in tumor metastases are indicated in the boxes with some key changes in gene expression indicated at each stage by the solid arrows.

Product Details

ISBN-13: 9789401781527
Publisher: Springer Netherlands
Publication date: 11/23/2014
Series: Cancer Metastasis - Biology and Treatment , #10
Edition description: 2007
Pages: 407
Product dimensions: 6.10(w) x 9.25(h) x 0.03(d)

Table of Contents

Chapter 1: Introduction: Metastasis as a Therapeutic Target

Richard J. Ablin and Malcolm D. Mason

Chapter 2: The Natural History of Prostate Cancer

David F. Penson and Peter C. Albertsen

Chapter 3: The Search for Genes Which Influence Prostate Cancer Metastasis: A Moving Target?

Norman J. Maitland

Chapter 4: Polyunsaturated Fatty Acids and Prostate Cancer Metastasis

Wen G. Jiang

Chapter 5: Role of Prostaglandin Synthesis and Cyclooxygenase-2 in Prostate Cancer and Metastasis

Alaa F. Badawi

Chapter 6: Cell Cycle Regulation

Ruchi M. Newman and Bruce R. Zetter

Chapter 7: Epithelial-Mesenchymal Molecular Interactions in Prostatic Tumor Cell Plasticity

Mary J.C. Hendrix, Jun Luo, Elisabeth A. Seftor, Navesh Sharma, Paul M. Heidger

Jr., Michael B. Cohen, Robert Bhatty, Jirapat Chungthapong, Richard E.B. Seftor, and David Lubaroff

Chapter 8: Orthotopic Metastatic Mouse Models of Prostate Cancer

Robert M. Hoffman

Chapter 9: ß-Catenin, its Binding Partners and Signalling Mechanisms: Implications in Prostate Cancer

Gaynor Davies, Gregory M. Harrison, and Malcolm D. Mason

Chapter 10: Hepayte Growth Factor/Scatter Factor and Prostate Cancer Metastasis

Gaynor Davies, Wen G. Jiang, and Malcolm D. Mason

Chapter 11: Matrix Degradation in Prostate Cancer

Michael J. Wilson and Akhouri A. Sinha

Chapter 12: The Biology of Bone Metastases from Prostate Cancer and the Role of Bisphosphonates

Noel W. Clarke and Herbert A. Fleisch

Chapter 13: Non-Steroidal Anti-Androgen Use as Part of Combined Androgen Blockade Therapy for Metastatic or Locally Advanced Prostate Cancer: a Review of the Evidence on Efficacy and Toxicity

Mike Shelley, Charles Bennett, Derek Nathan, and Oliver Sartor

Chapter 14: Strategies for the Implementation of Chemotherapy and Radiotherapy

Paula Scullin, Joe M. O’Sullivan, and Christopher C. Parker

Chapter15: Immuno-gene Therapy for Metastatic Prostate Cancer

Takefumi Satoh, Terry L. Timme, Yehoshua Gdor, Brian J. Miles, Robert J. Amato, Dov Kadmon, and Timothy C. Thompson

Chapter 16: Distilling the Past – Envisioning the Future

Richard J. Ablin and Malcolm D. Mason

From the B&N Reads Blog

Customer Reviews